Energy Metabolism in Thyroidectomized Patients
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
A PHASE2 clinical study on Hypothyroidism and Thyroid Cancer, this trial is completed. The trial is conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and has accumulated 10 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE2
-
Mar 2024 — Jun 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Aug 2023 — Mar 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 5 earlier versions
-
Jul 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Apr 2023 — Jul 2023 [monthly]
Recruiting PHASE2
-
May 2022 — Apr 2023 [monthly]
Recruiting PHASE2
-
May 2021 — May 2022 [monthly]
Recruiting PHASE2
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE2
First recorded
Oct 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Virginia Commonwealth University
For direct contact, visit the study record on ClinicalTrials.gov .